LPL Financial’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-95,601
| Closed | -$2.26M | – | 4960 |
|
|
2023
Q4 | $2.26M | Sell |
95,601
-27,763
| -23% | -$656K | ﹤0.01% | 2304 |
|
|
2023
Q3 | $1.84M | Sell |
123,364
-8,206
| -6% | -$122K | ﹤0.01% | 2362 |
|
|
2023
Q2 | $1.44M | Buy |
131,570
+12,741
| +11% | +$140K | ﹤0.01% | 2526 |
|
|
2023
Q1 | $1.04M | Buy |
118,829
+2,616
| +2% | +$22.8K | ﹤0.01% | 2721 |
|
|
2022
Q4 | $729K | Buy |
116,213
+20,619
| +22% | +$129K | ﹤0.01% | 2899 |
|
|
2022
Q3 | $335K | Buy |
95,594
+44,567
| +87% | +$156K | ﹤0.01% | 3466 |
|
|
2022
Q2 | $151K | Buy |
51,027
+1,155
| +2% | +$3.42K | ﹤0.01% | 3994 |
|
|
2022
Q1 | $155K | Sell |
49,872
-4,991
| -9% | -$15.5K | ﹤0.01% | 3871 |
|
|
2021
Q4 | $185K | Buy |
54,863
+21,165
| +63% | +$71.4K | ﹤0.01% | 3995 |
|
|
2021
Q3 | $123K | Sell |
33,698
-15,000
| -31% | -$54.8K | ﹤0.01% | 4068 |
|
|
2021
Q2 | $212K | Buy |
48,698
+15,065
| +45% | +$65.6K | ﹤0.01% | 3847 |
|
|
2021
Q1 | $153K | Buy |
33,633
+14,350
| +74% | +$65.3K | ﹤0.01% | 3817 |
|
|
2020
Q4 | $111K | Sell |
19,283
-76
| -0.4% | -$437 | ﹤0.01% | 3646 |
|
|
2020
Q3 | $140K | Buy |
19,359
+8,734
| +82% | +$63.2K | ﹤0.01% | 3284 |
|
|
2020
Q2 | $37K | Buy |
+10,625
| New | +$37K | ﹤0.01% | 3344 |
|
|
2019
Q4 | – | Sell |
-15,239
| Closed | -$78K | – | 3417 |
|
|
2019
Q3 | $78K | Buy |
15,239
+324
| +2% | +$1.66K | ﹤0.01% | 3162 |
|
|
2019
Q2 | $107K | Sell |
14,915
-323
| -2% | -$2.32K | ﹤0.01% | 3131 |
|
|
2019
Q1 | $202K | Sell |
15,238
-9,290
| -38% | -$123K | ﹤0.01% | 2920 |
|
|
2018
Q4 | $193K | Sell |
24,528
-894
| -4% | -$7.03K | ﹤0.01% | 2801 |
|
|
2018
Q3 | $282K | Buy |
+25,422
| New | +$282K | ﹤0.01% | 2740 |
|
|
2018
Q2 | – | Sell |
-10,000
| Closed | -$130K | – | 3274 |
|
|
2018
Q1 | $130K | Buy |
+10,000
| New | +$130K | ﹤0.01% | 3025 |
|